How do people with gastro-oesophageal reflux disease perceive their disease? Results of a multinational survey

Current Medical Research and Opinion

Volumn 23, Issue 11, 2007, Pages 2857-2865

  Ducrotté, Philippe ^a   Liker, Harley R ^b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gastro oesophageal reflux disease; Patient perceptions; Treatment satisfaction

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; BODY MASS; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HEALTH SURVEY; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT ATTITUDE; REVIEW;

ADOLESCENT; ADULT; DATA COLLECTION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED;

EID: 36348974569     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X233412     Document Type: Review

References (26)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20
2. Shaker R, Brunton S, Elfant A, et al. Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease. Aliment Pharmacol Ther 2004;20(Suppl 9):3-13
3. Orr WC, Goodrich S, Robert J. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther 2005;21:103-8
4. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006;101:18-28
5. DiPalma J. Management of severe gastroesophageal reflux disease. J Clin Gastroenterol 2001;32:19-26
6. Fennerty MB. Medical treatment of gastroesophageal reflux disease in the managed care environment. Semin Gastrointest Dis 1997;8:90-9
7. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80
8. Spechler SJ. Clinical manifestations and esophageal complications of GERD. Am J Med Sci 2003;326:279-84
9. Lagergren J, Bergström R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31
10. Ruigómez A, García Rodríguez LA, Wallander MA, et al. Esophageal stricture: incidence, treatment patterns, and recurrence rate. Am J Gastroenterol 2006;101:2685-92
11. Higuchi D, Sugawa C, Shah SH, et al. Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital. J Gastrointest Surg 2003;7:836-42
12. Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-55
13. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17
14. Heading RC. Review article: diagnosis and clinical investigation of gastro-oesophageal reflux disease: a European view. Aliment Pharmacol Ther 2004;20(Suppl 8):9-13
15. Jones R, Armstrong D, Malfertheiner P, Ducrotté P. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin 2006;22:657-62
16. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200
17. Aro P, Storskrubb T, Ronkainen J, et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006;163:1025-34
18. King A, MacDonald C, Örn C. Understanding gastroesophageal reflux disease (GERD): a patient-segmentation analysis. Poster presented at the XXXVIII Nordic Meeting of Gastroenterology, June 6-9 2007; Reykjavic, Iceland
19. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000;14:1589-94
20. Rey E, Moreno-Elola-Olaso C, Rodriguez-Artalejo F, et al. Medical consultation for gastro-oesophageal reflux symptoms: reasons and associated factors. Digestion 2004;70:173-7
21. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211
22. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med 2006;166:965-71
23. Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001;18:1367-72
24. Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995;9(Suppl 1):3-7
25. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-8
26. Ford AC, Forman D, Bailey AG, et al. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study. Am J Gastroenterol 2007;102:957-65